期刊文献+

左旋肉毒碱改善血液透析患者营养不良的效果分析

暂未订购
导出
摘要 目的观察血液透析患者中营养不良的影响因素,及时干预,纠正营养不良。方法选择30例病情稳定、透析1年以上的维持性血液透析患者,将其随机分两组。治疗组14例于透析后静脉注射左旋肉毒碱1.0 g,每周2次,疗程6个月。对照组16例静脉注射等剂量的生理盐水。测定前后干体重、血清白蛋白、血红蛋白变化。结果治疗组干体重、血清白蛋白、血红蛋白显著提高(P<0.05或0.01)。对照组上述指标无显著性变化(P>0.05)。结论尿毒症维持性血液透析患者中多种因素会造成营养不良,必须及早加强干预,应用左旋肉毒碱能更好地改善患者生活质量,无不良反应。
作者 杜金华
出处 《右江医学》 2008年第6期665-666,共2页 Chinese Youjiang Medical Journal
  • 相关文献

参考文献6

二级参考文献24

  • 1Mayer G,Graf H, Legenstein E, et al. L carnitine substitutionin patients on chronic hemodiaiysis. Nephron, 1989, 52:295-299.
  • 2Broderick TI,Panagakis G, DiDomenico D, et al. L- carnitine improvement of cardiac function is associated with a stimulation inglucose but not fatty acid metabolism in carnitine-deficient hearts. Cardiovasc Res, 1995,30:815-820.
  • 3Krahenbuhl S. Physiologic bases for the use of L-carnitine in cardiology. Schweiz-Rundsch-Med-Prax, 1998, 87:102-107.
  • 4Guarnieri G, Situlin R. Camitine metabolism in uremia. Am J Kidney, 2001,38 : 63-67.
  • 5Bergstrom J, Lindholm B, Malnutrition, et al. Cardiac disease and mortality: An intergrated point of view. Am J Kidney Dis,1998, 32: 834-841.
  • 6Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and survival in hemodialysis patients. Kidney Int, 1998,54 : 236-244.
  • 7Vescovo G, Ravara B, Gobbo V, et al. L-Camitine: a potential treatment for blocking apoptosis and preventing skeletal musule myopathy in heart failure. Am J Physiol Cell Physiol, 2002,283: 802-810.
  • 8Panichi V, Migliori M, De Pietro S, et al. C-reactive-protein as a marker of cytokine inflammation in uremic patients. Blood Purif, 2000, 18: 183-190.
  • 9Boenisch O, Ehmke KD, Heddergott A, et al. C-reactive-protein and cytokine plasma levels in hemodialysis patients. J Am Soc Nephrol, 2002, 15 : 547-551.
  • 10Panichi V, Migliori M, De Pietro S, et al. The link of biocompatibility to cytokine production. Kidney Int Suppl, 2000, 76:96-103.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部